Mark Stockbridge is the Director of Research Operations at Immunocore, where they currently manage Phase 4 clinical performance studies and conduct Real World Data analysis. Previously, Mark gained extensive experience in life sciences consultancy at Deloitte, leading teams in portfolio strategy and advanced analytics solutions. They also served as Head of Post-deployment Performance Evaluation & Monitoring at the UK Health Security Agency, and have a background as a chartered accountant and biomarker scientist at AstraZeneca. Mark holds a Master of Biology from the University of Bath and is an ACA with a 100% first-time pass rate.
This person is not in any teams
This person is not in any offices